CARD9 and Chronic mucocutaneous candidosis: Human CARD9 deficiency (Q295X, a defective CARD9 protein with the glutamine at residue 295 substituting) was first reported in 2009 in a large consanguineous family with chronic mucocutaneous candidiasis (CMC) (128).